Low plasma leptin levels contribute to diabetic hyperphagia in rats

Citation
Dk. Sindelar et al., Low plasma leptin levels contribute to diabetic hyperphagia in rats, DIABETES, 48(6), 1999, pp. 1275-1280
Citations number
46
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETES
ISSN journal
00121797 → ACNP
Volume
48
Issue
6
Year of publication
1999
Pages
1275 - 1280
Database
ISI
SICI code
0012-1797(199906)48:6<1275:LPLLCT>2.0.ZU;2-3
Abstract
The adipocyte hormone leptin reduces food intake in normal animals. During uncontrolled type 1 diabetes, plasma leptin levels fall, whereas food intak e increases. To test the hypothesis that low leptin levels contribute to di abetic hyperphagia, we investigated the effect on food intake of replacemen t of leptin at basal plasma concentrations for 7 days in Long-Evans rats wi th uncontrolled diabetes induced by streptozotocin (STZ). One group of STZ diabetic rats received saline (STZ + Sal) (n = 11), while the other group ( STZ + Lep) (n = 15) received a subcutaneous infusion of recombinant rat lep tin (100 mu g . kg(-1) . day(-1)) via osmotic minipumps. A nondiabetic cont rol group (Con) (n = 11) received saline only. In the STZ + Sal group, plas ma leptin levels decreased by 75% (P < 0.05) from 2.4 +/- 0.5 on the day be fore STZ/citrate buffer vehicle (Veh) injection (day 0) to 0.6 +/- 0.2 ng/m l on day 7. In contrast, plasma leptin levels on days 3-7 were comparable t o pretreatment values in both the STZ + Lep group (day 0: 2.6 +/- 0.4 vs, d ay 7: 2.5 +/- 0.3 ng/ml, NS) and the Con group (day 0: 3.8 +/- 0.4 vs, day 7: 2.9 +/- 1.0 ng/ml, NS). In the STZ + Sal group, daily food intake increa sed gradually to values 43% above basal by day 7 (day 0: 24 +/- 2 to day 7: 33 +/- 3 g, P < 0.05), whereas food intake did not increase in either the STZ + Lep group (day 0: 24 +/- 1 vs, day 7: 21 +/- 2 g, NS), or the Con gro up (day 0: 23 +/- 1 vs. day 7: 23 +/- 2 g). Plasma glucose levels exceeded nondiabetic control values (7.7 +/- 0.2 mmol/l) in both diabetic groups, bu t were lower in the STZ + Lep group (17.2 +/- 1.8 mmol/l) than in the STZ Sal group (24.3 +/- 1.1 mmol/l, P < 0.05). To determine if sensitivity to leptin-induced anorexia was affected by STZ treatment, a second experiment was performed in which the effect of intracerebroventricular leptin injecti on (at doses of 0.35, 1.0, or 3.5 mu g) on food intake was measured 10 days after STZ or Veh treatment. Leptin suppressed both 4- and 24-h food intake in the two groups to an equal extent at every dose (by 15, 22, and 35%, re spectively). These findings support the hypothesis that the effect of uncon trolled diabetes to lower leptin levels contributes to diabetic hyperphagia and that this effect is not due to altered leptin sensitivity.